Fundz

O. James Sterling Appointed as Chief Financial Officer of Bluebird Bio, Inc.

RECENTLY ACQUIREDMay 29, 2024

Position

Chief Executive Officer

Company

bluebird bio

Andrew Obenshain
aobenshain@bluebirdbio.com
SomervilleBiotechnologyHealth CareTherapeutics

Description

O. James Sterling has been appointed as the new chief financial officer (CFO) of bluebird bio, Inc., effective June 10, 2024. He brings extensive experience in the healthcare sector and knowledge of the capital markets, positioning the company well for its path to profitability.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at bluebird bio, and when

A new leader at bluebird bio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day bluebird bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at bluebird bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at bluebird bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

bluebird bio

Location

455 Grand Union Boulevard

Somerville, Massachusetts, United States

About

bluebird bio is a commercial-stage biotherapeutics company focused on developing and delivering gene therapies for severe genetic diseases. With more than a decade of scientific leadership in gene therapy and three FDA-approved therapies for sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy, the company is committed to ensuring access, reliability, and patient-centered care.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment bluebird bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Tom
Senior decision-maker at this company
••••••••@••••••••

See Tom's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for bluebird bio's next move

Learn about Strategic plan

bluebird bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.